Sino Biopharmaceutical (1177.HK) Financial Analysis & Valuation | Quarter Chart
Sino Biopharmaceutical (1177.HK)
1177.HKPrice: $0.56
Fair Value: 🔒
🔒score
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company'... more
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and developmen... more
Description
Shares
| Market Cap | $10.03B | Exchange | HKSE |
| Sector | Healthcare | Industry | Biotechnology |
| Country | HK | CEO | S Y Tse |
| IPO Date | 2003-12-08 | CAGR | 0.19% |
| Employees | 21,435 | Website | www.sinobiopharm.com |
| Div. Yield | 3.3% | Payout Ratio | — |
| Buy Back Yield | 0.22% | Total Yield | 3.52% |
1177.HK chart loading...
Fundamentals
Technicals
| Enterprise Value | $107.07B | P/E Ratio | 29.05 |
| Forward P/E | 17.2 | PEG Ratio | — |
| P/S Ratio | 1.33 | P/B Ratio | 1.4 |
| P/CF Ratio | 13.52 | P/FCF Ratio | 14.68 |
| EPS | $0.02 | EPS Growth 1Y | 24.28% |
| EPS Growth 3Y | -69.08% | EPS Growth 5Y | -33.06% |
| Revenue Growth 1Y | 10.28% | Gross Margin | 0.82% |
| Operating Margin | 0.22% | Profit Margin | 0.07% |
| ROE | 0.07% | ROA | 0.03% |
| ROCE | 0.14% | Current Ratio | 1.37 |
| Quick Ratio | 1.28 | Cash Ratio | 0.29 |
| Debt/Equity | 0.52 | Interest Coverage | — |
| Altman Z Score | 2.73 | Piotroski Score | 6 |